ATF6 and prostate carcinoma: Interestingly, according to the information from the previous publications, TUSC3 exerts its regulating effects on UPR, and TUSC3-deficiency specifically activates ATF6-branch mediated UPR to promote cancer development and metastasis in prostate cancer (29) and non-small cell lung cancer (16).